Balance Sheet Data

BioMarin Pharmaceutical Inc. (BMRN)

$105.56

+2.54 (+2.47%)

Year
A/P
2017
Actual
2018
Actual
2019
Actual
2020
Actual
2021
Actual
2022
Projected
2023
Projected
2024
Projected
2025
Projected
2026
Projected
Total Cash 1,395.971,084.31753.811,065.391,013.871,350.561,472.811,606.121,751.501,910.04
Total Cash (%)
Account Receivables 261.37342.63377.40448.35373.40440.30480.16523.62571.02622.70
Account Receivables (%)
Inventories 475.77530.87680.27698.55776.67770.54840.28916.34999.281,089.73
Inventories (%)
Accounts Payable 166.62207.62240.98191.43193247.61270.02294.46321.12350.18
Accounts Payable (%)
Capital Expenditure -199.22-144.62-163.41-137.52-119.22-194.50-212.11-231.31-252.24-275.07
Capital Expenditure (%)



To support growth, companies need to keep investing in capital items – including property, plants and equipment.
To calculate this net investment,we take capital expenditure (found in the company’s statement of cash flows) and subtract non-cash depreciation (found on the income statement).
Working capital refers to the cash a company needs for day-to-day operations.
The faster a company expands, the more cash it will need.
To calculate working capital, we take current assets and subtract current liabilities.
You can find both of these on a company’s balance sheet, which is published in its quarterly and annual financial statements.